首页> 外文OA文献 >Manufacturing Different Types of Solid Dispersions of BCS Class IV Polyphenol (Daidzein) by Spray Drying: Formulation and Bioavailability
【2h】

Manufacturing Different Types of Solid Dispersions of BCS Class IV Polyphenol (Daidzein) by Spray Drying: Formulation and Bioavailability

机译:通过喷雾干燥制造不同类型的BCS IV类多酚(Daidzein)的固体分散体:配方和生物利用度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Daidzein (DZ) is a polyphenolic compound belonging to Biopharmaceutical Classification System class IV, which shows that it may have limited therapeutic effects due to its low solubility and poor bioavailability. This study aimed to obtain high-purity DZ and prepare and characterize different types of solid dispersions (SDs) in order to enhance aqueous solubility and bioavailability. Excipients were investigated in order to manufacture different types of solid dispersions (SDs). Second-generation solid dispersions (SG), third-generation solid dispersions (TG), and second- and third-generation pH-modulated solid dispersions (SD and TG pHM-SD) were produced via spray drying. The SDs were characterized and tested for in vitro DZ release and oral bioavailability. SDs have shown increased aqueous solubility and in vitro release rate. Solid-state characterization showed that DZ was in an amorphous state in most of the formulations. The enhanced aqueous solubility of TG-pHM SD was reflected by an increase in oral bioavailability, which significantly increased the maximum plasma concentration approximately 20-fold and decreased the time to reach the maximum plasma concentration. The production of pHM SDs that contain DZ via spray drying is a simple and effective approach for oral drug delivery, which has the potential to greatly reduce the dose and enhance therapeutics effects.
机译:Daidzein(DZ)是属于生物制药分类系统IV类的多酚化合物,其表明,由于其低溶解度和生物利用度差,它可能具有有限的治疗效果。该研究旨在获得高纯度DZ,并制备和表征不同类型的固体分散体(SDS),以提高水溶性和生物利用度。研究了赋形剂以制造不同类型的固体分散体(SDS)。通过喷雾干燥制备第二代固体分散体(SG),第三代固体分散体(Tg)和第二代和第三代pH调制的固体分散体(SD和Tg PHM-SD)。表征和测试SDS的体外DZ释放和口服生物利用度。 SDS显示出增加的含水溶解度和体外释放速率。固态表征显示DZ在大部分制剂中处于非晶态。通过口服生物利用度的增加反映了TG-PHM SD的增强的水溶性,这显着增加了大约20倍的最大血浆浓度并降低了达到最大血浆浓度的时间。通过喷雾干燥含有DZ的PHM SDS的生产是口服药物递送的简单有效的方法,这具有大大减少剂量和增强治疗效果的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号